Erika Garner-Spitzer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Combination Therapy

Respiratory Syndrome Coronavirus

Allergic Rhinitis

Epidermal Growth Factor Receptor

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Angelika Wagner, Erika Garner-Spitzer, Claudia Auer, Pia Gattinger, Ines Zwazl, René Platzer, Maria Orola-Taus, Peter Pichler, Fabian Amman, Andreas Bergthaler, Johannes B Huppa, Hannes Stockinger, Christoph C Zielinski, Rudolf Valenta, Michael Kundi, Ursula Wiedermann
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants. Vaccines 12 (5) (2024)
Angelika Wagner, Erika Garner-Spitzer, Claudia Auer, Pia Gattinger, Ines Zwazl, René Platzer, Maria Orola-Taus, Peter Pichler, Fabian Amman, Andreas Bergthaler, Johannes B Huppa, Hannes Stockinger, Christoph C Zielinski, Rudolf Valenta, Michael Kundi, Ursula Wiedermann
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants. Vaccines 12 (5) (2024)
Joshua Tobias, Marina Maglakelidze, Zoran Andrić, Dinara Ryspayeva, Iurie Bulat, Ivan Nikolić, Zoran Petrovic, Tanuj Chawla, Rajnish Nagarkar, Erika Garner-Spitzer, Christoph C Zielinski, Leslie Mi Ok Chong, Bonnie Nixon, Nicholas J Ede, Sharon Yavrom, Michael Kundi, Ursula Wiedermann
Phase II trial of HER-Vaxx, a B cell peptide-based vaccine, in HER2-overexpressing advanced gastric cancer patients under platinum-based chemotherapy (HERIZON). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy 79 (2) (2023)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy (2023)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy 79 (2) (2023)
Joshua Tobias, Sandra Högler, Martin Raigel, Diego Shih-Chieh Lin, Yee Chao, Lukas Kenner, Erika Garner-Spitzer, Sharon Yavrom, Nicholas J Ede, Christoph C Zielinski, Michael Kundi, Ursula Wiedermann
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International journal of molecular sciences 25 (1) (2023)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy 79 (2) (2023)
Joshua Tobias, Sandra Högler, Martin Raigel, Diego Shih-Chieh Lin, Yee Chao, Lukas Kenner, Erika Garner-Spitzer, Sharon Yavrom, Nicholas J Ede, Christoph C Zielinski, Michael Kundi, Ursula Wiedermann
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International journal of molecular sciences 25 (1) (2023)
Joshua Tobias, Sandra Högler, Martin Raigel, Diego Shih-Chieh Lin, Yee Chao, Lukas Kenner, Erika Garner-Spitzer, Sharon Yavrom, Nicholas J Ede, Christoph C Zielinski, Michael Kundi, Ursula Wiedermann
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International journal of molecular sciences 25 (1) (2023)
Pia Gattinger, Bernhard Kratzer, Inna Tulaeva, Katarzyna Niespodziana, Anna Ohradanova-Repic, Laura Gebetsberger, Kristina Borochova, Erika Garner-Spitzer, Doris Trapin, Gerhard Hofer, Walter Keller, Isabella Baumgartner, Amra Tancevski, Khaitov M R, Alexander Karaulov, Hannes Stockinger, Ursula Wiedermann, Winfried F Pickl, Rudolph Valenta
Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants. Allergy 77 (8) (2022)
Joshua Tobias, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C Zielinski, Ursula Wiedermann
Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 14 (22) (2022)
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Maximilian Koblischke, Nikolaus Hommer, Angelika Wagner, Margareta Mayer, Lorenz Schubert, Lukas Hartl, Karin Kozbial, Philipp Hofer, Felix Kartnig, Thomas Hummel, Andreas Kerschbaumer, Thomas Deimel, Antonia Puchner, Venugopal Gudipati, Renate Thalhammer, Petra Munda, Keziban Uyanik-Ünal, Andreas Zuckermann, Gottfried Novacek, Thomas Reiberger, Erika Garner-Spitzer, Roman Reindl-Schwaighofer, Renate Kain, Stefan Winkler, Josef S Smolen, Karin Stiasny, Gottfried F Fischer, Thomas Perkmann, Helmuth Haslacher, Markus Zeitlinger, Ursula Wiedermann, Judith H Aberle, Daniel Aletaha, Leonhard X Heinz, Michael Markus Bonelli
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial. Nature communications 13 (1) (2022)